GSK cuts jobs in U.S. restructuring

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said it will lay off an unspecified number of U.S. employees in both R&D and commercial operations by YE2015.

GSK said most layoffs will occur among its drug discovery, development and clinical trials teams in Research Triangle Park, N.C. ...